Jeffrey Falk
- Molecular Biology top 10%
- Cellular and Molecular Neuroscience top 5%
- Ophthalmology top 5%
- Endocrine and Autonomic Systems top 10%
- Cell Biology
- Co-authors
- Marina P. AntochLjuba LyassLinda L.Y. ChunFarhang FarhangfarM L AppleburyLeslie C. BaxterJon RobbinsKaren Kage
- Topics
- Retinal Development and Disorders (4 papers)Epigenetics and DNA Methylation (3 papers)Acute Myeloid Leukemia Research (2 papers)
- Partner nations
- United StatesJapanSpain
In The Last Decade
Jeffrey Falk
15 papers receiving 870 citations
Peers
Comparison fields: 5 of 79
- Molecular Biology 726
- Cellular and Molecular Neuroscience 416
- Ophthalmology 114
- Endocrine and Autonomic Systems 98
- Cell Biology 98
Countries citing papers authored by Jeffrey Falk
This map shows the geographic impact of Jeffrey Falk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Falk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Falk more than expected).
Fields of papers citing papers by Jeffrey Falk
This network shows the impact of papers produced by Jeffrey Falk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Falk. The network helps show where Jeffrey Falk may publish in the future.
Co-authorship network of co-authors of Jeffrey Falk
This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Falk. A scholar is included among the top collaborators of Jeffrey Falk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Falk. Jeffrey Falk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | Using ChIP-based technologies to identify epigenetic modifications in disease-relevant cells. | 2 |
| 4 | Epigenetics & Sequencing - Gene Expression Systems' Second International Meeting. Chromatin methylation to disease biology & theranostics. | 2 |
| 5 | Cytokines and inflammation - GTCbio's sixth annual conference. | 1 |
| 6 | 2 | |
| 7 | 0 | |
| 8 | 127 | |
| 9 | 456 | |
| 10 | 5 | |
| 11 | 4 | |
| 12 | 22 | |
| 13 | 150 | |
| 14 | 80 | |
| 15 | 6 | |
| 16 | 30 |
About Jeffrey Falk
Jeffrey Falk is a scholar working on Hematology, Biomaterials and Endocrine and Autonomic Systems, having authored 16 papers that have together received 889 indexed citations. Recurring topics across this work include Retinal Development and Disorders (4 papers), Epigenetics and DNA Methylation (3 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (416 citations), Endocrine and Autonomic Systems (98 citations) and Ophthalmology (114 citations). Jeffrey Falk has collaborated with scholars based in United States, Japan and Spain. Frequent co-authors include Marina P. Antoch, Ljuba Lyass, Linda L.Y. Chun, Farhang Farhangfar, M L Applebury, Leslie C. Baxter, Jon Robbins, Karen Kage, Meredithe Applebury and John G. Flannery. Their work appears in journals such as Neuron, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.